Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rubin, Jaime L.
121  Ergebnisse:
Personensuche X
?
1

Impact of age at ivacaftor initiation on pulmonary outcomes..:

Merlo, Christian A ; McGarry, Lisa J ; Thorat, Teja...
Thorax.  , 2024
Link: https://doi.org/10.1136/..
 
?
2

Letter to the editor: A contemporary assessment of CFTR mod..:

Rubin, Jaime L. ; Kreindler, James L.
Journal of Cystic Fibrosis.  23 (2024)  2 - p. 368-369 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Long-term impact of ivacaftor on mortality rate and health ..:

Merlo, Christian A ; Thorat, Teja ; DerSarkissian, Maral...
Thorax.  , 2024
Link: https://doi.org/10.1136/..
 
?
4

Elexacaftor/tezacaftor/ivacaftor projected survival and lon..:

Lopez, Andrea ; Daly, Conor ; Vega-Hernandez, Gabriela..
Journal of Cystic Fibrosis.  22 (2023)  4 - p. 607-614 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Calibration and validation of modeled 5-year survival predi..:

McGarry, Lisa J. ; Bhaiwala, Zahra ; Lopez, Andrea...
PLOS ONE.  18 (2023)  4 - p. e0283479 , 2023
Link: https://doi.org/10.1371/..
 
?
6

PB2508: COMPARING DEFINITIONS OF EPISODES OF VASO-OCCLUSION..:

Locatelli, Franco ; LI, Nanxin ; Imren, Suzan...
HemaSphere.  7 (2023)  S3 - p. e6522522 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Limitations of standard cost-effectiveness methods for heal..:

Rubin, Jaime L. ; Lopez, Andrea ; Booth, Jason..
Journal of Medical Economics.  25 (2022)  1 - p. 783-791 , 2022
Link: https://doi.org/10.1080/..
 
?
8

Healthcare resource utilization and costs among children wi..:

Thorat, Teja ; McGarry, Lisa J. ; Bonafede, Machaon M....
Pediatric Pulmonology.  56 (2021)  9 - p. 2833-2844 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Modeling long-term health outcomes of patients with cystic ..:

Rubin, Jaime L. ; O'Callaghan, Lasair ; Pelligra, Christopher...
Therapeutic Advances in Respiratory Disease.  13 (2019)  - p. 175346661882018 , 2019
Link: https://doi.org/10.1177/..
 
?
10

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in pat..:

McColley, Susanna A. ; Konstan, Michael W. ; Ramsey, Bonnie W....
Journal of Cystic Fibrosis.  18 (2019)  1 - p. 94-101 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Cost-effectiveness of Telaprevir Combination Therapy for Ch..:

Brogan, Anita J. ; Talbird, Sandra E. ; Thompson, James R....
PLoS ONE.  9 (2014)  3 - p. e90295 , 2014
Link: https://doi.org/10.1371/..
 
?
12

Poster 189 Effects of Orthopaedic Surgery History on Throwi..:

Rubin, Jaime ; Chen, Cong ; Vincent, Kevin R..
PM&R.  6 (2014)  9S - p. , 2014
Link: https://doi.org/10.1016/..
 
?
13

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) ..:

McGarry, Lisa J ; Gilmore, Kristen E ; Rubin, Jaime L...
BMC Infectious Diseases.  13 (2013)  1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
14

Economic model of a birth cohort screening program for hepa..:

McGarry, Lisa J. ; Pawar, Vivek S. ; Panchmatia, Hemangi R....
Hepatology.  55 (2012)  5 - p. 1344-1355 , 2012
Link: https://doi.org/10.1002/..
 
?
15

Modeling the impact of the 13-valent pneumococcal conjugate..:

Strutton, David R ; Farkouh, Raymond A ; Rubin, Jaime L...
BMC Infectious Diseases.  12 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
1-15